Marta Chesi Selected Research

LCL161

1/2022	Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma.
12/2016	IAP antagonists induce anti-tumor immunity in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Chesi Research Topics

Disease

39	Multiple Myeloma 02/2024 - 05/2004
32	Neoplasms (Cancer) 05/2024 - 07/2002
5	Disease Progression 01/2019 - 12/2015
3	Chromothripsis 05/2024 - 07/2023
3	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 10/2012
3	Paraproteinemias (Monoclonal Gammopathy) 07/2023 - 02/2008
3	Inflammation (Inflammations) 01/2019 - 11/2002
2	Infections 01/2022 - 02/2018
2	Trisomy (Trisomies) 01/2020 - 09/2005
1	Leukemia 04/2024
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Bone Diseases (Bone Disease) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2019
1	Neuroblastoma 02/2018
1	Reoviridae Infections 02/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Residual Neoplasm 08/2015
1	Anemia 06/2015
1	Carcinoma (Carcinomatosis) 05/2014
1	Lymphoma (Lymphomas) 10/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 09/2023 - 05/2005
5	Immunoglobulins (Immunoglobulin)IBA 05/2024 - 03/2013
5	Bortezomib (Velcade)FDA Link 01/2022 - 03/2013
4	NF-kappa B (NF-kB)IBA 05/2024 - 08/2007
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 09/2005
2	Peptides (Polypeptides)IBA 05/2024 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 05/2024 - 07/2023
2	LCL161IBA 01/2022 - 12/2016
2	Immunomodulating AgentsIBA 01/2022 - 01/2017
2	Proteasome InhibitorsIBA 01/2022 - 11/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 07/2002
2	CytokinesIBA 12/2019 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 12/2018
2	Biomarkers (Surrogate Marker)IBA 02/2018 - 12/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2017 - 12/2015
2	UbiquitinIBA 11/2017 - 12/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 04/2009
2	ChromatinIBA 10/2015 - 03/2008
2	Cyclin DIBA 03/2013 - 05/2008
1	APOBEC-1 DeaminaseIBA 05/2024
1	Chimeric Antigen ReceptorsIBA 04/2024
1	Adenosine Monophosphate (AMP)IBA 01/2024
1	NIMA-Related KinasesIBA 10/2023
1	Drug CombinationsIBA 09/2023
1	Intracellular Signaling Peptides and ProteinsIBA 01/2023
1	YKL-5-124IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023
1	Therapeutic UsesIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Clofazimine (Lamprene)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	pomalidomideIBA 01/2021
1	6- amino- N- (3- (4- (4- morpholinyl)pyrido(3',2'- 4,5)furo(3,2- d)pyrimidin- 2- yl)phenyl)- 3- pyridinecarboxamideIBA 01/2020
1	apilimodIBA 01/2020
1	APY0201IBA 01/2020
1	Conditioned Culture MediaIBA 11/2019
1	Protein Disulfide-IsomerasesIBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	Blocking AntibodiesIBA 12/2018
1	Capsid Proteins (Capsid Protein)IBA 02/2018
1	Caspase 3 (Caspase-3)IBA 02/2018
1	Karyopherins (Importin)IBA 02/2018
1	InterleukinsIBA 01/2018
1	Interleukin-18 (Interleukin 18)IBA 01/2018
1	AntigensIBA 01/2018
1	LipidsIBA 01/2018
1	CB-5083IBA 11/2017
1	ATPases Associated with Diverse Cellular ActivitiesIBA 11/2017
1	AntibodiesIBA 01/2017
1	B-Cell Maturation AntigenIBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	Interferon Type IIBA 12/2016
1	130-nm albumin-bound paclitaxelIBA 12/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	Fibrinolysin FDA Link 01/2016
1	Chromogranin AIBA 01/2016
1	HydrolasesIBA 12/2015
1	HepcidinsIBA 06/2015
1	IronIBA 06/2015
1	Erythropoietin FDA Link 06/2015
1	Monoclonal AntibodiesIBA 08/2014
1	Proteoglycans (Proteoglycan)IBA 05/2014
1	Versicans (Versican)IBA 05/2014
1	Growth Differentiation Factor 15IBA 01/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 03/2013
1	VaccinesIBA 10/2012

Therapy/Procedure

12	Therapeutics 02/2024 - 05/2008
8	Immunotherapy 04/2024 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2020 - 06/2014
2	Transplantation 01/2019 - 07/2012
1	Stem Cell Transplantation 01/2022